H. Lundbeck A/S et al v. Cipla Limited et al > Summary
Court Case Number 1:18-cv-00753
Filing Date May 17, 2018
Termination Date Apr 22, 2020
Court Delaware District Court
Status Dismissed - Settled
JudgesLeonard P. Stark
Plaintiff Attorneys
9Takeda Pharmaceutical Company Limited
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
Takeda Pharmaceuticals North America
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
Takeda Pharmaceutical Company Limited
Attorney Name: Maryellen Noreika
Morris Nichols Arsht & Tunnell
Takeda Pharmaceutical Company Limited
Attorney Name: George F. Pappas
Covington & Burling LLP
Takeda Pharmaceutical Company Limited
Attorney Name: Einar Stole
Covington & Burling LLP
Takeda Pharmaceutical Company Limited
Attorney Name: Christopher N. Sipes
Covington & Burling LLP
Takeda Pharmaceutical Company Limited
Attorney Name: Brianne Bharkhda Sullivan
Covington & Burling LLP
Takeda Pharmaceutical Company Limited
Attorney Name: Priscilla G. Dodson
Covington & Burling LLP
Defendant Attorneys
4Cipla limited
Attorney Name: Karen L. Pascale
Young Conaway Stargatt & Taylor
Cipla limited
Attorney Name: Robert M. Vrana
Young Conaway Stargatt & Taylor
Cipla USA
Attorney Name: Karen L. Pascale
Young Conaway Stargatt & Taylor
Cipla USA
Attorney Name: Robert M. Vrana
Young Conaway Stargatt & Taylor
Counter Defendant
3Counter Claimant
4Cipla limited
Attorney Name: Karen L. Pascale
Young Conaway Stargatt & Taylor
Cipla limited
Attorney Name: Robert M. Vrana
Young Conaway Stargatt & Taylor
Cipla USA
Attorney Name: Karen L. Pascale
Young Conaway Stargatt & Taylor
Cipla USA
Attorney Name: Robert M. Vrana
Young Conaway Stargatt & Taylor
Cause
35:271 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 09861630 | 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment | Jan 9, 2018 |
